CCR5 and cancer: Currently, other CCR5 blockers (e.g., cenicriviroc, leronlimab) are being tested to treat HIV infection and other inflammatory conditions, and maraviroc emerges as a potential drug to treat other diseases involving CCR5, especially some types of cancer (77).